LifeStance Health Group Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
27 Nov 24 | SellUS$565,500 | Robert Bessler | Individual | 75,000 | US$7.54 | |
13 Nov 24 | SellUS$78,523 | Lisa Miller | Individual | 10,540 | US$7.45 | |
23 Aug 24 | SellUS$33,089 | Ann Varanakis | Individual | 5,269 | US$6.28 | |
12 Jun 24 | SellUS$332,143 | Ryan Pardo | Individual | 61,508 | US$5.40 | |
11 Jun 24 | SellUS$470,564 | Kevin Mullins | Individual | 85,093 | US$5.53 | |
10 Jun 24 | SellUS$436,322 | Danish Qureshi | Individual | 83,109 | US$5.25 | |
24 May 24 | SellUS$85,843,814 | TPG Capital, L.P. | Company | 14,573,017 | US$5.89 | |
24 May 24 | SellUS$22,395,812 | Summit Partners, L.P. | Company | 3,802,345 | US$5.89 | |
24 May 24 | SellUS$12,439,851 | Silversmith Management, L.P. | Company | 2,112,029 | US$5.89 | |
13 May 24 | SellUS$362,567 | Paula Cipollone | Individual | 50,278 | US$7.22 | |
01 Apr 24 | SellUS$76,882 | Danish Qureshi | Individual | 12,965 | US$5.93 | |
01 Apr 24 | SellUS$57,450 | Kevin Mullins | Individual | 9,688 | US$5.93 | |
01 Apr 24 | SellUS$59,988 | Pablo Pantaleoni | Individual | 10,116 | US$5.93 | |
01 Apr 24 | SellUS$58,292 | Ryan Pardo | Individual | 9,830 | US$5.93 | |
15 Mar 24 | SellUS$1,347,719 | Kenneth Burdick | Individual | 214,605 | US$6.28 | |
14 Mar 24 | SellUS$249,301 | Ryan Pardo | Individual | 39,384 | US$6.33 | |
14 Mar 24 | SellUS$281,938 | Kevin Mullins | Individual | 44,540 | US$6.33 | |
13 Mar 24 | SellUS$972,920 | Danish Qureshi | Individual | 153,943 | US$6.32 | |
12 Mar 24 | SellUS$292,735 | Pablo Pantaleoni | Individual | 43,304 | US$6.76 | |
11 Mar 24 | SellUS$407,664 | David Bourdon | Individual | 58,826 | US$6.93 | |
11 Mar 24 | SellUS$106,958 | Ann Varanakis | Individual | 15,434 | US$6.93 | |
11 Mar 24 | SellUS$96,992 | Paula Cipollone | Individual | 13,996 | US$6.93 | |
03 Jan 24 | SellUS$25,099 | Paula Cipollone | Individual | 3,369 | US$7.45 |
Insider Trading Volume
Insider Buying: LFST insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 50,318,256 | 12.6% |
Institutions | 145,653,549 | 36.5% |
VC/PE Firms | 202,643,976 | 50.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
160,711,618 | US$1.2b | 0% | 3.01% | |||
41,932,358 | US$305.7m | 0% | 11.81% | |||
36,812,734 | US$268.4m | -15.6% | 0.02% | |||
17,916,554 | US$130.6m | 0% | no data | |||
15,953,887 | US$116.3m | 0% | no data | |||
10,832,325 | US$79.0m | 30% | no data | |||
10,567,961 | US$77.0m | 0% | no data | |||
10,441,068 | US$76.1m | -15.8% | 0.51% | |||
9,904,578 | US$72.2m | 7.08% | no data | |||
6,700,304 | US$48.8m | 0% | no data | |||
6,380,320 | US$46.5m | -2.07% | 0.05% | |||
4,830,441 | US$35.2m | 15.2% | 0.01% | |||
4,650,571 | US$33.9m | 0% | no data | |||
4,539,225 | US$33.1m | -35.1% | no data | |||
4,536,731 | US$33.1m | 94.5% | no data | |||
4,116,766 | US$30.0m | 6.05% | 0.01% | |||
3,452,178 | US$25.2m | 26.8% | no data | |||
3,297,959 | US$24.0m | 0% | no data | |||
3,101,000 | US$22.6m | -35.8% | 0.76% | |||
2,987,599 | US$21.8m | -2.45% | no data | |||
2,884,238 | US$21.0m | 305% | 0.01% | |||
2,750,656 | US$20.1m | 4.67% | no data | |||
2,371,505 | US$17.3m | 0% | no data | |||
2,136,942 | US$15.6m | 9.47% | 0.01% | |||
1,881,139 | US$13.7m | 85.1% | no data |
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 16:24 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
LifeStance Health Group, Inc. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Stephanie Davis | Barclays |
Jamie Perse | Goldman Sachs |
Jamie Perse | Goldman Sachs |